These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 10632083)

  • 41. Cardiovascular and renal effects of alpha-trinositol in ischemic heart failure rats.
    Sun XY; Feng QP; Zhao X; Edvinsson L; Hedner T
    Life Sci; 1995; 57(12):1197-211. PubMed ID: 7674809
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Enhanced Y1-receptor-mediated vasoconstrictive action of neuropeptide Y (NPY) in superior mesenteric arteries in portal hypertension.
    Wiest R; Jurzik L; Moleda L; Froh M; Schnabl B; von Hörsten S; Schölmerich J; Straub RH
    J Hepatol; 2006 Mar; 44(3):512-9. PubMed ID: 16324766
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Direct evidence for the role of neuropeptide Y in sympathetic nerve stimulation-induced vasoconstriction.
    Han S; Yang CL; Chen X; Naes L; Cox BF; Westfall T
    Am J Physiol; 1998 Jan; 274(1):H290-4. PubMed ID: 9458879
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Neuropeptide Y suppresses epileptiform activity in rat frontal cortex and hippocampus in vitro via different NPY receptor subtypes.
    Bijak M
    Neurosci Lett; 1999 Jun; 268(3):115-8. PubMed ID: 10406018
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Vascular neuropeptide Y Y1-receptors in the rat kidney: vasoconstrictor effects and expression of Y1-receptor mRNA.
    Modin A; Malmström RE; Meister B
    Neuropeptides; 1999 Aug; 33(4):253-9. PubMed ID: 10657500
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The first highly potent and selective non-peptide neuropeptide Y Y1 receptor antagonist: BIBP3226.
    Rudolf K; Eberlein W; Engel W; Wieland HA; Willim KD; Entzeroth M; Wienen W; Beck-Sickinger AG; Doods HN
    Eur J Pharmacol; 1994 Dec; 271(2-3):R11-3. PubMed ID: 7705422
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Role of NPY Y1 receptors in cardiovascular control in the conscious rabbit.
    Serone AP; Wright CE; Angus JA
    J Cardiovasc Pharmacol; 2000 Feb; 35(2):315-21. PubMed ID: 10672867
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Neuropeptide Y and the nonpeptide antagonist BIBP 3226 share an overlapping binding site at the human Y1 receptor.
    Sautel M; Rudolf K; Wittneben H; Herzog H; Martinez R; Munoz M; Eberlein W; Engel W; Walker P; Beck-Sickinger AG
    Mol Pharmacol; 1996 Aug; 50(2):285-92. PubMed ID: 8700135
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pharmacology of H 394/84, a dihydropyridine neuropeptide Y Y(1) receptor antagonist, in vivo.
    Malmström RE; Balmér KC; Weilitz J; Nordlander M; Sjölander M
    Eur J Pharmacol; 2001 Apr; 418(1-2):95-104. PubMed ID: 11334870
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Regional involvement of an endothelium-derived contractile factor in the vasoactive actions of neuropeptide Y in bovine isolated retinal arteries.
    Prieto D; Simonsen U; Nyborg NC
    Br J Pharmacol; 1995 Nov; 116(6):2729-37. PubMed ID: 8590997
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of dipeptidyl peptidase iv inhibition on arterial blood pressure.
    Jackson EK; Dubinion JH; Mi Z
    Clin Exp Pharmacol Physiol; 2008 Jan; 35(1):29-34. PubMed ID: 18047624
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antagonistic regulation of alpha 2-adrenoceptors by neuropeptide Y receptor subtypes in the nucleus tractus solitarii.
    Yang SN; Fior DR; Hedlund PB; Agnati LF; Fuxe K
    Eur J Pharmacol; 1994 Dec; 271(1):201-12. PubMed ID: 7698202
    [TBL] [Abstract][Full Text] [Related]  

  • 53. alpha-Trinositol: a functional (non-receptor) neuropeptide Y antagonist in vasculature.
    Sun X; You J; Hedner T; Erlinge D; Fellström B; Yoo H; Wahlestedt C; Edvinsson L
    J Pharm Pharmacol; 1996 Jan; 48(1):77-84. PubMed ID: 8722501
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evidence for involvement of neuropeptide Y receptors in the regulation of food intake: studies with Y1-selective antagonist BIBP3226.
    Kask A; Rägo L; Harro J
    Br J Pharmacol; 1998 Aug; 124(7):1507-15. PubMed ID: 9723965
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Neuropeptide Y modulates the vascular response to periarterial nerve stimulation primarily by a postjunctional action in the isolated perfused rat kidney.
    Oellerich WF; Malik KU
    J Pharmacol Exp Ther; 1993 Sep; 266(3):1321-9. PubMed ID: 8371140
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Neuropeptide Y induced inhibition of noradrenaline release in rat hypothalamus: role of receptor subtype and nitric oxide.
    Bitran M; Tapia W; Eugenín E; Orio P; Boric MP
    Brain Res; 1999 Dec; 851(1-2):87-93. PubMed ID: 10642831
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Possible involvement of neuropeptide Y Y1 receptors in antidepressant like effect of agmatine in rats.
    Kotagale NR; Paliwal NP; Aglawe MM; Umekar MJ; Taksande BG
    Peptides; 2013 Sep; 47():7-11. PubMed ID: 23816796
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evidence that stimulation of two modalities of pituitary luteinizing hormone release in ovarian steroid-primed ovariectomized rats may involve neuropeptide Y Y1 and Y4 receptors.
    Jain MR; Pu S; Kalra PS; Kalra SP
    Endocrinology; 1999 Nov; 140(11):5171-7. PubMed ID: 10537146
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Neuropeptide Y and ATP interact to control renovascular resistance in the rat.
    Oberhauser V; Vonend O; Rump LC
    J Am Soc Nephrol; 1999 Jun; 10(6):1179-85. PubMed ID: 10361855
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Angiotensin II modulates the cardiovascular responses to microinjection of NPY Y1 and NPY Y2 receptor agonists into the nucleus tractus solitarii of the rat.
    Díaz-Cabiale Z; Fuxe K; Coveñas R; González-Barón S; Narváez JA
    Brain Res; 2003 Sep; 983(1-2):193-200. PubMed ID: 12914980
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.